派林生物：上半年净利润2.36亿元，同比下降27.89%

Core Insights - The company reported a revenue of 986 million yuan for the first half of 2025, representing a year-on-year decline of 13.18% [1] - The net profit for the same period was 236 million yuan, showing a year-on-year decrease of 27.89% [1] - The company announced plans not to distribute cash dividends, issue bonus shares, or convert reserves into share capital [1] Financial Performance - Revenue for H1 2025: 986 million yuan, down 13.18% year-on-year [1] - Net profit for H1 2025: 236 million yuan, down 27.89% year-on-year [1] Dividend Policy - The company will not distribute cash dividends [1] - No bonus shares will be issued [1] - No conversion of reserves into share capital is planned [1]